CDH1 and metastatic melanoma: Together, these results show that in the same way as in M2 cells, treatment with Gö6976, but not with Gö6983, induces N- to E-cadherin switch and reversion of the pro-metastatic phenotype in the M4T2 metastatic melanoma cells.